Abstract:Coordinated by Dr Rory Collins from Oxford, the data for the third international study of infarct survival (ISIS-3) came from investigators in nearly 1 000 hospitals in Europe, North America, and Aust...Coordinated by Dr Rory Collins from Oxford, the data for the third international study of infarct survival (ISIS-3) came from investigators in nearly 1 000 hospitals in Europe, North America, and Australasia who had treated over 46 000 patients suffering an acute myocardial infarction with one of three randomly assigned fibrinolytic agents : streptokinase, anistreplase, or tissue plasminogen activator (tPA)Read More